Pilot Study on the Clinical Utility of the Tulsa Life Chart

August 25, 2026 updated by: Robin Aupperle, Laureate Institute for Brain Research, Inc.

Pilot Study on the Clinical Utility of the Tulsa Life Chart: A Graphical Representation of Patient Life History

The proposed study aims to examine the usability, utility, and feasibility of the Tulsa Life Chart (TLC) in a sample of patients seeking mental health treatment and their healthcare providers. The TLC is an interactive, web-based application used to create a graphical interface for visualizing a patient's life history.

Study Overview

Detailed Description

Understanding the longitudinal course of mental health is critical for case conceptualization. One approach for capturing the complexity of an individual's illness course is to depict it graphically. The first attempt for this method was the National Institute of Mental Health Life Chart for Bipolar Disorder. Subsequent research indicated Life Charts are useful clinically and time- and cost-effective. Despite clinical utility and time and cost efficiency, this approach has not been widely adopted in the mental health field. Possible explanations are the prior focus on bipolar disorder, time required to collect information, and prior versions have not had automatic translation of the patient information into an image.

The Tulsa Life Chart (TLC) was developed by researchers at the Laureate Institute for Brain Research (LIBR). The TLC was developed to address weaknesses of previous life chart methods and help patients and healthcare professionals (HCPs) quickly identify patterns of mental health symptoms across diagnostic categories. To date only one formal exploration of the TLC has been conducted in a sample of individuals with mood, anxiety, eating disorders, and substance use disorders, which suggested that participants felt the TLC was helpful in understanding their mental health symptoms and was pleasant to complete. Unpublished focus groups with HCPs suggest HCPs believe the TLC could help to improve patient encounters by increasing understanding of patients and facilitating conversations. Based on these findings the goal of the proposed study is to examine clinical usability, utility, and feasibility in a pragmatic pilot trial.

The current trial will recruit individuals seeking treatment within the Laureate Psychiatric Clinic and Hospital and healthcare professionals involved with their care. Treatment-seeking patients who are invited to participate will be asked to complete the TLC soon after establishing care in a health system setting. Subsequently, the patient's HCP will review the chart during the intake process and complete several measures related to the chart and their experience (baseline assessment point). Patients and HCPs will engage in treatment as usual in between the TLC and assessment time points. Prior to or shortly following discharge/termination of treatment (approximately 4 to 12 weeks depending on the clinic), patients and HCPs will be asked to again complete questions to determine the TLC's usefulness during treatment. The overarching aim of the current study is to examine the usefulness of the Tulsa Life Chart for treatment-seeking individuals and healthcare professionals.

Study Type

Observational

Enrollment (Actual)

63

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oklahoma
      • Tulsa, Oklahoma, United States, 74008
        • Laureate Institute for Brain Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Indviduals seeking mental health treatment and their healthcare providers who have been invited to participate in the study.

Description

Inclusion Criteria:

Treatment Seekers Inclusion Criteria:

  1. Actively seeking mental health treatment at Laureate Psychiatric Clinic and Hospital
  2. Provision of informed consent or if <18 assent and parental consent
  3. Age 15 to 65 years
  4. Necessary resources to engage in a technology-based intervention
  5. English proficiency
  6. Willingness to grant access to medical records

HCPs Inclusion Criteria:

  1. Employed at Laureate Psychiatric Clinic and Hospital in a patient care role
  2. Informed consent
  3. English proficiency
  4. Access to resources to engage in technology-based intervention

Exclusion Criteria:

Treatment Seekers Exclusion Criteria:

  1. Active suicidal ideation with plan or intent
  2. No access to resources to participate in a technology-based intervention
  3. Completed more than 2 sessions of therapy with their current provider prior to enrollment in the study
  4. Not proficient in English

HCPs Exclusion Criteria:

  1. No access to resources to participate in a technology-based intervention
  2. Not proficient in English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Treatment seeking individuals
Individuals seeking treatment in the Laureate Psychiatric Clinic and Hospital (LPCH).
The TLC is a self-administered, interactive assessment of patient history. Participants are asked to provide information from birth to their current age in developmental epochs (i.e., ages 0 to 5; 6 to 10; 11 to 14; 15 to 18; 19 to 25; 26 to 35; and so on in 10-year increments). Participants are first asked to rate their average mood during the epoch. They are then asked about locations lived, schools attended, people they were close to, hobbies, medical conditions, medications, hospitalizations, direct and indirect substance use exposure, mental health symptoms, mental health treatment, and important life events. The information is then displayed in an interactive, graphic of the individual's life that is reviewable by the patient and the healthcare providers enrolled in the study that the patient consents to having access.
Healthcare professionals
Healthcare professionals (HCPS) include nurses, psychologists, therapists, medical doctors, dieticians, etc who work at LPCH and are engaged in direct patient care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mHealth App Usability Questionnaire (MAUQ) Total Usability Score (Patient)
Time Frame: Baseline assessment
Validated self-report survey in which participants indicate how usable the assessment tool was, with scores ranging from 18 to 126. Higher scores indicate greater usability.
Baseline assessment
mHealth App Usability Questionnaire (MAUQ) Total Usability Score (Healthcare Professional)
Time Frame: Baseline assessment
Validated self-report survey in which healthcare professional participants indicate how usable the assessment tool was, with scores ranging from 18 to 126. Higher scores indicate greater usability.
Baseline assessment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mHealth App Usability Questionnaire (MAUQ) - Ease of Use Subscale (Patient)
Time Frame: Baseline assessment
Subscale of a validated self-report survey in which patient participants report how easy the assessment tool was to use. Ease of use scores range from 5 to 35 with higher scores indicating greater ease of use.
Baseline assessment
mHealth App Usability Questionnaire (MAUQ) - Ease of Use Subscale (Healthcare Professional)
Time Frame: Baseline assessment
Subscale of a validated self-report survey in which healthcare professional participants report how easy the assessment tool was to use. Ease of use scores range from 5 to 35 with higher scores indicating greater ease of use.
Baseline assessment
mHealth App Usability Questionnaire (MAUQ) - Interface and Satisfaction Subscale (Patient)
Time Frame: Baseline assessment
Subscale of a validated self-report survey in which patients rate their satisfaction with the assessment tool and the interface of the tool. Interface and satisfaction scores range from 7 to 49 with higher scores indicating greater satisfaction.
Baseline assessment
mHealth App Usability Questionnaire (MAUQ) - Interface and Satisfaction Subscale (Healthcare Professional)
Time Frame: Baseline assessment
Subscale of a validated self-report survey in which healthcare professionals rate their satisfaction with the assessment tool and the interface of the tool. Interface and satisfaction scores range from 7 to 49 with higher scores indicating greater satisfaction.
Baseline assessment
mHealth App Usability Questionnaire (MAUQ) - Usefulness Subscale (Patient)
Time Frame: Baseline assessment
Subscale of a validated self-report survey in which patients rate the usefulness of the assessment tool. Usefulness scores range from 6 to 42 with higher scores indicating greater usefulness.
Baseline assessment
mHealth App Usability Questionnaire (MAUQ) - Usefulness Subscale (Healthcare Professional)
Time Frame: Baseline assessment
Subscale of a validated self-report survey in which healthcare professionals rate the usefulness of the assessment tool. Usefulness scores range from 6 to 42 with higher scores indicating greater usefulness.
Baseline assessment
Time spent to complete the Tulsa Life Chart (Patient)
Time Frame: Baseline assessment
Treatment seekers self-report of time to complete the TLC and embedded time count from the TLC application.
Baseline assessment
Time spent to reviewing the Tulsa Life Chart (Healthcare Professional)
Time Frame: Baseline assessment
Healthcare professionals' self-report of time spent reviewing the TLC and embedded time count from the TLC application.
Baseline assessment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
mHealth App Usability Questionnaire (MAUQ) Total Usability Score (Patient)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
Validated self-report survey in which participants indicate how usable the assessment tool was, with scores ranging from 18 to 126. Higher scores indicate greater usability.
Assessment two - on average 4 to 12 weeks after baseline assessment
Change in perception of usefulness
Time Frame: Change from baseline to the post-treatment timepoint, approximately 4 - 12 weeks after baseline
Change in mHealth App Usability Questionnaire (MAUQ) score from first assessment time point to second assessment time point. Scores on the MAUQ range from 18 to 126. Higher scores indicate greater usability.
Change from baseline to the post-treatment timepoint, approximately 4 - 12 weeks after baseline
mHealth App Usability Questionnaire (MAUQ) - Ease of Use Subscale (Patient)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
Subscale of a validated self-report survey in which patient participants report how easy the assessment tool was to use. Ease of use scores range from 5 to 35 with higher scores indicating greater ease of use.
Assessment two - on average 4 to 12 weeks after baseline assessment
mHealth App Usability Questionnaire (MAUQ) - Ease of Use Subscale (Healthcare Professional)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
Subscale of a validated self-report survey in which healthcare professional participants report how easy the assessment tool was to use. Ease of use scores range from 5 to 35 with higher scores indicating greater ease of use.
Assessment two - on average 4 to 12 weeks after baseline assessment
mHealth App Usability Questionnaire (MAUQ) - Interface and Satisfaction Subscale (Patient)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
Subscale of a validated self-report survey in which patients rate their satisfaction with the assessment tool and the interface of the tool. Interface and satisfaction scores range from 7 to 49 with higher scores indicating greater satisfaction.
Assessment two - on average 4 to 12 weeks after baseline assessment
mHealth App Usability Questionnaire (MAUQ) - Interface and Satisfaction Subscale (Healthcare Professional)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
Subscale of a validated self-report survey in which healthcare professionals rate their satisfaction with the assessment tool and the interface of the tool. Interface and satisfaction scores range from 7 to 49 with higher scores indicating greater satisfaction.
Assessment two - on average 4 to 12 weeks after baseline assessment
mHealth App Usability Questionnaire (MAUQ) - Usefulness Subscale (Patient)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
Subscale of a validated self-report survey in which patients rate the usefulness of the assessment tool. Usefulness scores range from 6 to 42 with higher scores indicating greater usefulness.
Assessment two - on average 4 to 12 weeks after baseline assessment
mHealth App mHealth App Usability Questionnaire (MAUQ) - Usefulness Subscale (Healthcare Professional)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
Subscale of a validated self-report survey in which healthcare professionals rate the usefulness of the assessment tool. Usefulness scores range from 6 to 42 with higher scores indicating greater usefulness.
Assessment two - on average 4 to 12 weeks after baseline assessment
Utility Questionnaire (Patient)
Time Frame: Baseline assessment
This measure was created for the purpose of the current study to measure how useful the assessment tool was in multiple domains. This measure asks treatment seekers questions pertaining to their experience using the Tulsa Life Chart including: ease of understanding and impact of completing the Tulsa Life Chart on remembering life events, understanding of mental health patterns, communication with their provider, and motivation for treatment engagement. Scores range from 6 to 28 with higher scores indicating greater utility for patients.
Baseline assessment
Utility Questionnaire (Healthcare Professional)
Time Frame: Baseline assessment
This measure was created for the purpose of the current study to measure how useful the assessment tool was in multiple domains. This measure asks healthcare professionals questions pertaining to their experience viewing their patient's Tulsa Life Chart. Domains include ease of understanding the chart; usefulness in diagnosing their patient; and impact on understanding patient's psychosocial history, understanding patterns in their patient's mental health, and facilitating conversations. Scores range from 7 to 35 with higher scores indicating greater utility for healthcare professionals.
Baseline assessment
Utility Questionnaire (Patient)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
This measure was created for the purpose of the current study to measure how useful the assessment tool was in multiple domains. This measure asks treatment seekers questions pertaining to their experience using the Tulsa Life Chart including: ease of understanding and impact of completing the Tulsa Life Chart on remembering life events, understanding of mental health patterns, communication with their provider, and motivation for treatment engagement. Scores range from 5 to 23 with higher scores indicating greater utility for patients.
Assessment two - on average 4 to 12 weeks after baseline assessment
Utility Questionnaire (Healthcare Professional)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
This measure was created for the purpose of the current study to measure how useful the assessment tool was in multiple domains. This measure asks healthcare professionals questions pertaining to their experience viewing their patient's Tulsa Life Chart. Domains include impact on therapy; ease of understanding the chart; usefulness in diagnosing their patient; and impact on understanding patient's psychosocial history, understanding patterns in their patient's mental health, and facilitating conversations. Scores range from 8 to 35 with higher scores indicating greater utility for healthcare professionals.
Assessment two - on average 4 to 12 weeks after baseline assessment
Likelihood of recommending the Tulsa Life Chart to other patients (Patient)
Time Frame: Baseline assessment
One question will be used to assess the patient's likelihood of recommending the Tulsa Life Chart. "How likely are you to recommend the Tulsa Life Chart to someone else who may be experiencing mental health symptoms?" Scores range from 1 to 5, with higher scores indicating greater likelihood of recommending to the chart.
Baseline assessment
Likelihood of recommending the Tulsa Life Chart to other healthcare professionals (Healthcare Professional)
Time Frame: Baseline assessment
One question will be used to assess the patient's likelihood of recommending the Tulsa Life Chart to other healthcare professionals. "Based on this experience, how likely are you to recommend the Tulsa Life Chart to other providers?" Scores range from 1 to 5, with higher scores indicating greater likelihood of recommending to the chart.
Baseline assessment
Likelihood of recommending the Tulsa Life Chart to other patients (Patient)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
One question will be used to assess the patient's likelihood of recommending the Tulsa Life Chart. "How likely are you to recommend the Tulsa Life Chart to someone else who may be experiencing mental health symptoms?" Scores range from 1 to 5, with higher scores indicating greater likelihood of recommending to the chart.
Assessment two - on average 4 to 12 weeks after baseline assessment
Likelihood of recommending (Healthcare Professional)
Time Frame: Assessment two - on average 4 to 12 weeks after baseline assessment
One question will be used to assess the patient's likelihood of recommending the Tulsa Life Chart to other healthcare professionals. "Based on this experience, how likely are you to recommend the Tulsa Life Chart to other providers?" Scores range from 1 to 5, with higher scores indicating greater likelihood of recommending to the chart.
Assessment two - on average 4 to 12 weeks after baseline assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robin Aupperle, PhD, Laureate Institute for Brain Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2022

Primary Completion (Actual)

January 31, 2024

Study Completion (Actual)

January 31, 2024

Study Registration Dates

First Submitted

August 22, 2022

First Submitted That Met QC Criteria

August 30, 2022

First Posted (Actual)

August 31, 2022

Study Record Updates

Last Update Posted (Actual)

August 27, 2026

Last Update Submitted That Met QC Criteria

August 25, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022-004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The current study is enrolling participants from a specific treatment center and the data being collected and visualized as part fo the Tulsa Life Chart would be able to be used to potentially identify the individual participants. Thus, no data from this study will be shared through open access databases. If the visualization data from the TLC is shared for publication, data will be modified to for participant confidentiality and privacy. Data obtained from questionnaire measures may be shared upon request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe